Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Ellen Y. T. Chien,1
Wei Liu,1
Qiang Zhao,1
Vsevolod Katritch,2
Gye Won Han,1
Michael A. Hanson,3
Lei Shi,4
Amy Hauck Newman,5
Jonathan A. Javitch,6
Vadim Cherezov,1
Raymond C. Stevens1,*
Abstract:
Dopamine modulates movement, cognition, and emotion throughactivation of dopamine G protein–coupled receptors inthe brain. The crystal structure of the human dopamine D3 receptor(D3R) in complex with the small molecule D2R/D3R-specific antagonisteticlopride reveals important features of the ligand bindingpocket and extracellular loops. On the intracellular side ofthe receptor, a locked conformation of the ionic lock and twodistinctly different conformations of intracellular loop 2 areobserved. Docking of R-22, a D3R-selective antagonist, revealsan extracellular extension of the eticlopride binding site thatcomprises a second binding pocket for the aryl amide of R-22,which differs between the highly homologous D2R and D3R. Thisdifference provides direction to the design of D3R-selectiveagents for treating drug abuse and other neuropsychiatric indications.
1 Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. 2 Skaggs School of Pharmacy and Pharmaceutical Sciences, and San Diego Supercomputer Center, University of California, San Diego, La Jolla, CA 92093, USA. 3 Receptos, 10835 Road to the Cure, Suite 205, San Diego, CA 92121, USA. 4 Department of Physiology and Biophysics and HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, Cornell University, 1300 York Avenue, New York, NY 10021, USA. 5 Medicinal Chemistry Section, National Institute on Drug Abuse–Intramural Research Program, Baltimore, MD 21224, USA. 6 Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, Columbia University College of Physicians and Surgeons, 630 West 168th, New York, NY 10032, USA.
* To whom correspondence should be addressed. E-mail: stevens{at}scripps.edu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Valda Vinson (23 November 2010) Sci. Signal.3 (149), ec358.
[DOI: 10.1126/scisignal.3149ec358] |Abstract »
EDITORS' CHOICE
Valda Vinson (23 November 2010) Sci. Signal.3 (149), ec359.
[DOI: 10.1126/scisignal.3149ec359] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Structural Basis for Molecular Recognition at Serotonin Receptors.
C. Wang, Y. Jiang, J. Ma, H. Wu, D. Wacker, V. Katritch, G. W. Han, W. Liu, X.-P. Huang, E. Vardy, et al. (2013)
Science
340, 610-614
|Abstract »|Full Text »|PDF »
Structure of the Human Angiotensin II Type 1 (AT1) Receptor Bound to Angiotensin II from Multiple Chemoselective Photoprobe Contacts Reveals a Unique Peptide Binding Mode.
D. Fillion, J. Cabana, G. Guillemette, R. Leduc, P. Lavigne, and E. Escher (2013)
J. Biol. Chem.
288, 8187-8197
|Abstract »|Full Text »|PDF »
In Vivo Occupancy of Dopamine D3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit-Hyperactivity Disorder.
V. Barth, A. B. Need, E. T. Tzavara, B. Giros, C. Overshiner, S. D. Gleason, M. Wade, A. M. Johansson, K. Perry, G. G. Nomikos, et al. (2013)
J. Pharmacol. Exp. Ther.
344, 501-510
|Abstract »|Full Text »|PDF »
Conopeptide {rho}-TIA Defines a New Allosteric Site on the Extracellular Surface of the {alpha}1B-Adrenoceptor.
L. Ragnarsson, C.-I. A. Wang, A. Andersson, D. Fajarningsih, T. Monks, A. Brust, K. J. Rosengren, and R. J. Lewis (2013)
J. Biol. Chem.
288, 1814-1827
|Abstract »|Full Text »|PDF »
Functional fusions of T4 lysozyme in the third intracellular loop of a G protein-coupled receptor identified by a random screening approach in yeast.
E. Mathew, F.-X. Ding, F. Naider, and M. E. Dumont (2013)
Protein Eng. Des. Sel.
26, 59-71
|Abstract »|Full Text »|PDF »
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012.
Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.
A. Kirkpatrick, J. Heo, R. Abrol, and W. A. Goddard III (2012)
PNAS
109, 19988-19993
|Abstract »|Full Text »|PDF »
Pharmacological Characterization and Modeling of the Binding Sites of Novel 1,3-Bis(pyridinylethynyl)benzenes as Metabotropic Glutamate Receptor 5-Selective Negative Allosteric Modulators.
C. Molck, K. Harpsoe, D. E. Gloriam, R. P. Clausen, U. Madsen, L. O. Pedersen, H. N. Jimenez, S. M. Nielsen, J. M. Mathiesen, and H. Brauner-Osborne (2012)
Mol. Pharmacol.
82, 929-937
|Abstract »|Full Text »|PDF »
Pleiotropic functions of the transmembrane domain 6 of human melanocortin-4 receptor.
The Thyrotropin Receptor Hinge Region as a Surrogate Ligand: Identification of Loci Contributing to the Coupling of Thyrotropin Binding and Receptor Activation.
C.-R. Chen, L. M. Salazar, S. M. McLachlan, and B. Rapoport (2012)
Endocrinology
153, 5058-5067
|Abstract »|Full Text »|PDF »
Helix 8 of leukotriene B4 receptor 1 inhibits ligand-induced internalization.
Y. Aratake, T. Okuno, T. Matsunobu, K. Saeki, R. Takayanagi, S. Furuya, and T. Yokomizo (2012)
FASEB J
26, 4068-4078
|Abstract »|Full Text »|PDF »
Modulation of Constitutive Activity and Signaling Bias of the Ghrelin Receptor by Conformational Constraint in the Second Extracellular Loop.
J. Mokrosinski, T. M. Frimurer, B. Sivertsen, T. W. Schwartz, and B. Holst (2012)
J. Biol. Chem.
287, 33488-33502
|Abstract »|Full Text »|PDF »
Computational and Experimental Analysis of the Transmembrane Domain 4/5 Dimerization Interface of the Serotonin 5-HT1A Receptor.
N. Gorinski, N. Kowalsman, U. Renner, A. Wirth, M. T. Reinartz, R. Seifert, A. Zeug, E. Ponimaskin, and M. Y. Niv (2012)
Mol. Pharmacol.
82, 448-463
|Abstract »|Full Text »|PDF »
New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors.
Naturally evolved G protein-coupled receptors adopt metastable conformations.
K.-Y. M. Chen, F. Zhou, B. G. Fryszczyn, and P. Barth (2012)
PNAS
109, 13284-13289
|Abstract »|Full Text »|PDF »
Ring Substituents on Substituted Benzamide Ligands Indirectly Mediate Interactions with Position 7.39 of Transmembrane Helix 7 of the D4 Dopamine Receptor.
S. S. Ericksen, D. F. Cummings, M. E. Teer, S. Amdani, and J. A. Schetz (2012)
J. Pharmacol. Exp. Ther.
342, 472-485
|Abstract »|Full Text »|PDF »
Automatic modeling of mammalian olfactory receptors and docking of odorants.
G. Launay, S. Teletchea, F. Wade, E. Pajot-Augy, J.-F. Gibrat, and G. Sanz (2012)
Protein Eng. Des. Sel.
25, 377-386
|Abstract »|Full Text »|PDF »
Critical features for biosynthesis, stability, and functionality of a G protein-coupled receptor uncovered by all-versus-all mutations.
K. M. Schlinkmann, A. Honegger, E. Tureci, K. E. Robison, D. Lipovsek, and A. Pluckthun (2012)
PNAS
109, 9810-9815
|Abstract »|Full Text »|PDF »
Structure of the First Sphingosine 1-Phosphate Receptor.
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
E. Ceraudo, R. Hierso, Y.-V. Tan, S. Murail, C. Rouyer-Fessard, P. Nicole, J.-C. Robert, N. Jamin, J.-M. Neumann, P. Robberecht, et al. (2012)
FASEB J
26, 2060-2071
|Abstract »|Full Text »|PDF »
Differential determinants for coupling of distinct G proteins with the class B secretin receptor.
G. L. Garcia, M. Dong, and L. J. Miller (2012)
Am J Physiol Cell Physiol
302, C1202-C1212
|Abstract »|Full Text »|PDF »
Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development.
K. O'Callaghan, A. Kuliopulos, and L. Covic (2012)
J. Biol. Chem.
287, 12787-12796
|Abstract »|Full Text »|PDF »
Conus Venom Peptide Pharmacology.
R. J. Lewis, S. Dutertre, I. Vetter, and M. J. Christie (2012)
Pharmacol. Rev.
64, 259-298
|Abstract »|Full Text »|PDF »
Crystal Structure of a Lipid G Protein-Coupled Receptor.
M. A. Hanson, C. B. Roth, E. Jo, M. T. Griffith, F. L. Scott, G. Reinhart, H. Desale, B. Clemons, S. M. Cahalan, S. C. Schuerer, et al. (2012)
Science
335, 851-855
|Abstract »|Full Text »|PDF »
Second Extracellular Loop of Human Glucagon-like Peptide-1 Receptor (GLP-1R) Has a Critical Role in GLP-1 Peptide Binding and Receptor Activation.
C. Koole, D. Wootten, J. Simms, L. J. Miller, A. Christopoulos, and P. M. Sexton (2012)
J. Biol. Chem.
287, 3642-3658
|Abstract »|Full Text »|PDF »
The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation.
C. E. Carroll, S. Marada, D. P. Stewart, J. X. Ouyang, and S. K. Ogden (2012)
Development
139, 612-621
|Abstract »|Full Text »|PDF »
The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery.
J. A. Salon, D. T. Lodowski, and K. Palczewski (2011)
Pharmacol. Rev.
63, 901-937
|Abstract »|Full Text »|PDF »
Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach.
S. Thiele, A. Steen, P. C. Jensen, J. Mokrosinski, T. M. Frimurer, and M. M. Rosenkilde (2011)
J. Biol. Chem.
286, 37543-37554
|Abstract »|Full Text »|PDF »
Alternative Coreceptor Requirements for Efficient CCR5- and CXCR4-Mediated HIV-1 Entry into Macrophages.
K. Cashin, M. Roche, J. Sterjovski, A. Ellett, L. R. Gray, A. L. Cunningham, P. A. Ramsland, M. J. Churchill, and P. R. Gorry (2011)
J. Virol.
85, 10699-10709
|Abstract »|Full Text »|PDF »
Role of the Transmembrane Domain 4/Extracellular Loop 2 Junction of the Human Gonadotropin-releasing Hormone Receptor in Ligand Binding and Receptor Conformational Selection.
Engineering a Prokaryotic Cys-loop Receptor with a Third Functional Domain.
R. Goyal, A. A. Salahudeen, and M. Jansen (2011)
J. Biol. Chem.
286, 34635-34642
|Abstract »|Full Text »|PDF »
Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data: MT7 SNAKE TOXIN BOUND TO DIMERIC hM1 MUSCARINIC RECEPTOR.
C. Marquer, C. Fruchart-Gaillard, G. Letellier, E. Marcon, G. Mourier, S. Zinn-Justin, A. Menez, D. Servent, and B. Gilquin (2011)
J. Biol. Chem.
286, 31661-31675
|Abstract »|Full Text »|PDF »
Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore.
M. Dong, P. C.- H. Lam, D. I. Pinon, K. Hosohata, A. Orry, P. M. Sexton, R. Abagyan, and L. J. Miller (2011)
J. Biol. Chem.
286, 23888-23899
|Abstract »|Full Text »|PDF »
Lipid cubic phase as a membrane mimetic for integral membrane protein enzymes.
Two distinct conformations of helix 6 observed in antagonist-bound structures of a {beta}1-adrenergic receptor.
R. Moukhametzianov, T. Warne, P. C. Edwards, M. J. Serrano-Vega, A. G. W. Leslie, C. G. Tate, and G. F. X. Schertler (2011)
PNAS
108, 8228-8232
|Abstract »|Full Text »|PDF »
Structure of an Agonist-Bound Human A2A Adenosine Receptor.
F. Xu, H. Wu, V. Katritch, G. W. Han, K. A. Jacobson, Z.-G. Gao, V. Cherezov, and R. C. Stevens (2011)
Science
332, 322-327
|Abstract »|Full Text »|PDF »
Recognition in the Face of Diversity: Interactions of Heterotrimeric G proteins and G Protein-coupled Receptor (GPCR) Kinases with Activated GPCRs.